Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Research

Systematic Review and Meta-Analyses of Incidence for Group B Streptococcus Disease in Infants and Antimicrobial Resistance, China

Yijun Ding, Yajuan WangComments to Author , Yingfen Hsia, Neal Russell, and Paul T. Heath
Author affiliations: National Center for Children’s Health, Beijing, China (Y. Ding, Y. Wang); University of London, London, UK (Y. Hsia, N. Russell, P.T. Heath); Queen’s University Belfast, Belfast, Northern Ireland, UK (Y. Hsia)

Main Article

Table 1

Characteristics of included studies and outcome types for systematic review and meta-analyses of incidence of group B Streptococcus disease in infants, China*

Characteristic Type and no. studies
Total, 64 Incidence, 14 CFR, 56 AMR, 20 Serotypes, 4 MLST, 2
China
Eastern 59 13 52 19 4 2
Central 2 0 2 0 0 0
Western 2 1 2 0 0 0
Northeastern
1
0
0
1
0
0
Hospital type
Mainland China
Tertiary 45 6 39 18 4 2
Secondary 9 3 9 2 0 0
Primary 1 0 1 0 0 0
Nonmainland China 0
Teaching 8 4 7 0 0 0
General
1
1
0
0
0
0
Study design
Prospective 4 3 3 0 1 1
Retrospective
60
11
53
20
3
1
Reporting period, days
Full, 0–89 53 11 46 16 4 2
Full EOGBS <1–6 7 3 6 2 0 0
Full LOGBS 7–89
4
0
4
2
0
0
Specimen type
Blood only 25 5 18 8 2 0
CSF only 6 0 6 3 0 0
Blood and CSF 23 6 22 9 2 2
All sterile sites 4 3 3 0 0 0
Blood and CSF plus sputum or gastric fluid
6
0
7
0
0
0
IAP
Any 10 6 9 3 1 1
None 4 0 3 2 0 0
Unknown 50 8 44 15 3 1

*AMR, antimicrobial resistance; CFR, case-fatality rate; CSF, cerebrospinal fluid; EOGBS, early onset group B Streptococcus; IAP, intrapartum antimicrobial drug prophylaxis; MLST, multilocus sequence typing; LOGBS, late onset group B Streptococcus.

Main Article

Page created: August 17, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external